Skip to content

Advertisement

Open Peer Review Reports for: Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
24 Nov 2016 Submitted Original manuscript
18 Jan 2017 Reviewed Reviewer Report - Kristin Zorn
1 Feb 2017 Reviewed Reviewer Report - Vijay Pandey
9 Mar 2017 Author responded Author comments - Charles-André Philip
Resubmission - Version 2
9 Mar 2017 Submitted Manuscript version 2
27 Jun 2017 Author responded Author comments - Charles-André Philip
Resubmission - Version 3
27 Jun 2017 Submitted Manuscript version 3
25 Jul 2017 Author responded Author comments - Charles-André Philip
Resubmission - Version 4
25 Jul 2017 Submitted Manuscript version 4
7 Aug 2017 Author responded Author comments - Charles-André Philip
Resubmission - Version 5
7 Aug 2017 Submitted Manuscript version 5
28 Aug 2017 Author responded Author comments - Charles-André Philip
Resubmission - Version 6
28 Aug 2017 Submitted Manuscript version 6
Publishing
1 Sep 2017 Editorially accepted
8 Sep 2017 Article published 10.1186/s12885-017-3639-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement